The relationship between diabetic retinopathy, glycemic control, risk factor indicators and patient education

Israel Medical Association Journal

Volumn 8, Issue 8, 2006, Pages 523-526

  Axer Siegel, Ruth ^a,b   Herscovici, Zvi ^a   Gabbay, Meirav ^a   Mimouni, Karin ^a   Weinberger, Dov ^a,b   Gabbay, Uri ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cholesterol level; Diabetic retinopathy; Glycemic control; HbAlc; Hypertension

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERTENSION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; QUESTIONNAIRE; RISK FACTOR; VISUAL ACUITY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY;

EID: 33748850186     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American Diabetes Association. Available at: URL:http://www.diabetes.org accessed May 20, 2005.
2. Summary Report 2004. Eligibility for Blindness Certificate. Service for the Blind, Ministry of Social Services, Jerusalem, Israel.
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
4. Leske MC, Wu SY, Hennis A, et al. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy. The Barbados Eye Studies. Ophthalmology 2005;112:799-805.
5. Klein R, Klein BE, Moss SE, Davis MD, De Mets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989;149:2427-32.
6. Chew EY, Klein ML, Ferris FL III, et al. for the ETDRS Research Group. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 1996;114:1079-84.
7. Klein BEK, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: X. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-5.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
9. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342:381-9.
10. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-9.
11. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
12. Do DV, Shah SM, Sung JU, Haller JA, Nguyen QD. Persistent diabetic macular edema is associated with elevated hemoglobin Alc. Am J Ophthalmol 2005;139:620-3.
13. Klein BEK, Klein R, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-9.
14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J 1998;317:703-13.
15. Rachmani R, Levi Z, Avin M, Ravid M. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with type 2 diabetes mellitus - a randomized prospective study. Diabet Med 2002;19385-92.